Comparative Efficacy Among 3rd Line Post-Imatinib Chronic Phase-Chronic Myeloid Leukemia (Cp-Cml) Patients After Failure Of Dasatinib Or Nilotinib Tyrosine Kinase Inhibitors
BLOOD(2014)
摘要
INTRODUCTION
更多查看译文
关键词
leukemia,dasatinib,kinase,post-imatinib,phase-chronic,cp-cml
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要